Plunkett Research Online: AveXis Inc

AVEXIS INC (AVXS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AveXis, Inc. is a clinical-stage gene therapy company, dedicated to developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. Its initial product candidate, AVXS-101, is a proprietary gene therapy currently in development for.....


AVEXIS INC

Ticker: AVXS
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 847-857-8280
Fax:
Address: 2275 Half Day Rd., Ste. 160
Bannockburn, IL 60015 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Sean P. NolanCEO
Thomas J. DeeCFO
See More
AveXis, Inc. is a clinical-stage gene therapy company, dedicated to developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. Its initial product candidate, AVXS-101, is a proprietary gene therapy currently in development for.....See More See More

$USD, In whole numbers 2016201520142013201220112010
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture